| # | Drug | Count |
|---|---|---|
| 0 | AMLODIPINE | 4 |
| 1 | PREDNISONE | 4 |
| 2 | TACROLIMUS | 4 |
| 3 | ASPIRIN | 3 |
| 4 | ASPIRIN 325 MG | 3 |
| 5 | ASPIRIN 81 MG | 3 |
| 6 | OMEPRAZOLE | 3 |
| 7 | OMEPRAZOLE MAGNESIUM | 3 |
| 8 | RIVAROXABAN | 3 |
| 9 | TRANEXAMIC ACID | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALBENDAZOLE | 1 | 0.0005 |
| 1 | TRANEXAMIC ACID | 3 | 0.0003 |
| 2 | BRIGATINIB | 1 | 0.0003 |
| 3 | DORZOLAMIDE | 2 | 0.0003 |
| 4 | TREMELIMUMAB | 1 | 0.0002 |
| 5 | TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM | 1 | 0.0001 |
| 6 | TOLVAPTAN | 2 | 0.0001 |
| 7 | BENZONATATE | 2 | 0.0001 |
| 8 | FOSCARBIDOPA/FOSLEVODOPA | 1 | 0.0001 |
| 9 | ACETYLCYSTEINE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 1 | 0.0003 |
| 1 | Antifibrinolytic Agent [EPC] | 3 | 0.0003 |
| 2 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 3 | Vasopressin V2 Receptor Antagonist [EPC] | 2 | 0.0001 |
| 4 | Non-narcotic Antitussive [EPC] | 2 | 0.0001 |
| 5 | Vitamin D Analog [EPC] | 1 | 0.0001 |
| 6 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | Prostaglandin Analog [EPC] | 2 | 0.0000 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |